LOGIN
No difference in function between stem cells and control during microfracture
September 2019
No difference in function between stem cells and control during microfracture
Study Type:Therapy
OE Level Evidence:N/A
Journal Level of Evidence:2
Transplantation of autologous bone marrow-derived mesenchymal stem cells under arthroscopic surgery with microfracture versus microfracture alone for articular cartilage lesions in the knee: A multicenter prospective randomized control clinical trial
Regen Ther. 2019;(11):106-113. doi: 10.1016/j.reth.2019.06.002Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
The authors randomized 14 patients who were undergoing microfracture to two groups: one group received bone marrow-derived mesenchymal stem cells (BMSCs), and the other group were controls. Outcomes included the Knee Injury and Osteoarthritis Outcome Score (KOOS), the International Knee Documentation Committee (IKDC), T2 time on magnetic resonance imaging, and the Magnetic Resonance Observation Ca...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.